Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Active & Responsive
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
for
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV,
Location: Halifax, Montreal, Toronto, Calgary
Sponsor: AstraZeneca
Sex: All
Age: 18
Code: NCT07509151
Phase 3, Recruiting
Active & Responsive
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
for
Metastatic Castration-resistant Prostate Cancer
Location: New York NY, Montreal, Myrtle Beach SC, Miami FL,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT07611110
Phase 3, Recruiting
Active & Responsive
Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis
for
Multiple Sclerosis
Location: Gatineau
Sponsor: Clinique Neuro-Outaouais
Sex: All
Age: 18 - 70
Code: NCT07159789
Recruiting
Active & Responsive
A Gaucher Disease Gene Therapy Trial With FLT201
for
Gaucher Disease Type 1
Location: New York NY, Hackensack NJ, Montreal, Philadelphia PA,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase 3, Recruiting
Active & Responsive
ARC101 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Montreal, Toronto, Vancouver
Sponsor: Third Arc Bio
Sex: All
Age: 18+
Code: NCT06672185
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Clinical Course Of Disease In Participants With FA-CM
for
Friedreich Ataxia, Cardiomyopathy
Location: Boston MA, Montreal, Tampa FL, Cincinnati OH,
Sponsor: Lexeo Therapeutics
Sex: All
Age: 6+
Code: NCT06865482
Recruiting
Active & Responsive
The Role of Cognition in Motor Learning After Stroke
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Fredericton, Quebec, New York NY, Montreal,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Boston MA, Farmington CT, New York NY, Burlington VT,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase 3, Recruiting
Active & Responsive
Effects of Infertility and Assisted Reproductive Technology on Sexual Function and Behavior
for
Infertility Assisted Reproductive Technology, Sexual Behavior,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: Female
Age: 18 - 44
Code: NCT07376109
Recruiting
Active & Responsive
Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
for
Type 1 Diabetes
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT06021145
Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: London, Halifax, Providence RI, New York NY, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase 2, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Halifax, Boston MA, Quebec, Sherbrooke,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Location: Mineola NY, New York NY, Montreal, Ottawa, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06428409
Phase 1, Phase 2, Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]